G
G-Flas
Biotech & Life Sciences · Seoul, South Korea · Founded 2014
Develops and manufactures products for the health and well-being of people MoreLess
GFLAS is a pioneering company in the field of CRISPR-based genome editing, offering advanced solutions for both research and therapeutic applications. The company specializes in the development and application of CRISPR CasN enzymes, which are used to precisely modify genetic material. GFLAS serves a diverse range of clients, including academic research institutions, biotechnology firms, and pharmaceutical companies, operating primarily in the biotechnology and life sciences markets.
The business model of GFLAS revolves around providing high-quality CRISPR products and services. This includes custom CRISPR CasN enzyme synthesis, genome editing services, and intellectual property licensing. The company generates revenue through the sale of these products and services, as well as through strategic partnerships and collaborations with other entities in the biotech sector.
GFLAS leverages its proprietary CRISPR technology to offer tailored solutions that meet the specific needs of its clients. By focusing on innovation and quality, the company aims to drive advancements in genetic research and therapeutic development. GFLAS's commitment to excellence is reflected in its robust R&D efforts and its collaborations with leading organizations in the field.
Keywords: CRISPR, genome editing, biotechnology, life sciences, enzyme synthesis, genetic research, therapeutic applications, intellectual property, biotech partnerships, custom solutions.
Company overview
G-Flas company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- Seoul, South Korea
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 35.2
Valuation & funding
G-Flas funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES EOther financing | Jun 2022 | $2.5M | $10M | SmileGate Investment | — |
| LATE VCOther financing | May 2021 | $235K | $939K | Undisclosed | — |
| SERIES COther financing | Jul 2019 | $10M | $40M | New Flight · SmileGate Investment · Alpenroute Asset Management | — |
| SERIES BOther financing | Jun 2018 | $12M | $47M | DS Asset Management · Timefolio Asset Management | — |
| SERIES AOther financing | Feb 2017 | $1.8M | $7.4M | Undisclosed | — |
| FundingOther financing | Jan 2016 | ActnerLab | ↗ | ||
| SPINOUTOther financing | Jan 2014 | Seoul National University | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 8 |
| 2025 | 8 |
| 2024 | 9 |
Growth signals
G-Flas website traffic
Latest recorded traffic for G-Flas is 430 monthly website visits, down 91.4% over the last three months. G-Flas's team grew 0% over the past year.
Comparisons
G-Flas compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
G-Flas's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on G-Flas's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where G-Flas has talent and traffic
team presence
In the news
Latest news about G-Flas
Recent press, funding announcements, and product moves mentioning G-Flas — open to read from the original sources.
Market sentiment
What the market is saying about G-Flas
An AI-synthesized read of the highest-engagement posts about G-Flas on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See G-Flas’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.